Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.370
-0.120 (-3.44%)
Feb 17, 2026, 11:13 AM EST - Market open
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.75 billion as of February 17, 2026. Its market cap has decreased by -42.17% in one year.
Market Cap
1.75B
Enterprise Value
1.24B
1-Year Change
-42.17%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.75B, a decrease of -65.44%. That is a compound annual growth rate of -19.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.82B | -14.67% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 1.88B |
| Sarepta Therapeutics | 1.86B |
| Stoke Therapeutics | 1.82B |
| Vericel | 1.82B |
| MBX Biosciences | 1.80B |
| RAPT Therapeutics | 1.78B |
| Syndax Pharmaceuticals | 1.78B |
| Olema Pharmaceuticals | 1.78B |